Back to Results
First PageMeta Content
Pharmaceutical sciences / Clinical surveillance / Adverse Event Reporting System / U.S. Consumer Product Safety Commission / Pharmacovigilance / Adverse effect / Food and Drug Administration / Patient safety / Adverse drug reaction / Medicine / Health / Pharmacology


ORIGINAL ARTICLE Evaluation and Overview of the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance Project (NEISS-CADES) Michael A. Jhung, MD, MPH,* Daniel S. Budnitz, MD, MPH,* A
Add to Reading List

Document Date: 2009-10-30 06:58:00


Open Document

File Size: 421,42 KB

Share Result on Facebook

City

Hyatsville / San Francisco / Boca Raton / Rockville / Washington / DC / Atlanta / West Sussex / /

Company

National Academy Press / Drug Characteristics / ADHD / Oxford University Press / Agency for Healthcare Research / Evaluating Public Health Surveillance Systems / Surveillance Attributes / Donaldson / Mendelsohn AB / John Wiley & Sons / ADEs / /

Country

United States / United Kingdom / /

/

Facility

Institute of Medicine / hospital EDs / /

IndustryTerm

subsequent processing / herbal products / therapeutic devices / reaction reporting systems / healthcare / outpatient healthcare settings / healthcare facilities / healthcare encounter / periodic site / passive reporting systems / physician order entry systems / consumer products / healthcare settings / treatment of ADE-related symptoms / pharmaceutical products / healthcare providers / guidelines working / /

MedicalCondition

choking / electronic injury / anaphylaxis / injury / MS / hypoglycemia / injection site infections / nonfatal injuries / patient injury / attention deficit hyperactivity disorder / attention deficit-hyperactivity disorder / angioedema / rash / drug-related injury / injuries / /

MedicalTreatment

medication errors / dietary supplements / immunizations / antibiotics / Pharmacotherapy / polypharmacy / /

NaturalFeature

Gahart MT / /

Organization

U.S. Department of Health and Human Services / Food and Drug Administration / Institute of Medicine / office of Workforce and Career Development / Division of Hazard and Injury Data Systems / Division of Healthcare Quality Promotion / Government Accountability Office / U.S. Department of Veterans Affairs Enterprise Reference Terminology / Division of Surveillance / Research and Communication Support / Centers for Disease Control and Prevention / Division of Hazard / National Center for Injury Prevention and Control / National Center for Health Statistics / Intelligence Service / Division of Surveillance / Oxford University / Consumer Product Safety Commission / Epidemic Intelligence Service / office of Drug Safety / US Department of Veterans Affairs / US General Accounting Office / Agency for Healthcare Research and Quality / /

Person

Jacqui Butler / Lee Annest / Cathy Irish / Kelly N. Weidenbach / Tom Schroeder / Joel Friedman / Shelley Elbert / Aaron B. Mendelsohn / Daniel A. Pollock / Theresa D. Nelson / Michael A. Jhung / Steve Brown / Daniel S. Budnitz / Benjamin Kupronis / Ann Intern / /

Position

private physician / physician / Officer / contractor / Governor / abstractor / treating physician / representative / NDF-RT / Kilbridge PM / /

Product

VA medication / digoxin / A-24 / /

ProvinceOrState

Sussex / Maryland / Georgia / /

PublishedMedium

Lippincott Williams & Wilkins / /

Technology

Diagnostic tests / /

URL

http /

SocialTag